Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BEAM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BEAM investment potential.

What is BEAM stock price today?

Get real-time BEAM stock price, historical data, and price charts on Financhill. Track BEAM performance with our advanced analysis tools.

Is BEAM a good investment?

Evaluate BEAM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BEAM stock?

To buy BEAM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BEAM?

View detailed market capitalization data and company valuation metrics for BEAM on our comprehensive analysis page.

What is the P/E ratio of BEAM?

Use our fundamental analysis tools to view BEAM P/E ratio and compare valuation metrics with industry peers.

What are BEAM earnings?

View BEAM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Beam Therapeutics, Inc. 10K Form

Sell

BEAM
Beam Therapeutics, Inc.

Last Price:

$27.22

Seasonality Move:

-25.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-08	10Q	BEAM/Beam Therapeutics, Inc. Quarterly
2023-08-08	10Q	BEAM/Beam Therapeutics, Inc. Quarterly
2023-05-10	10Q	BEAM/Beam Therapeutics, Inc. Quarterly
2022-11-07	10Q	BEAM/Beam Therapeutics, Inc. Quarterly
2022-08-09	10Q	BEAM/Beam Therapeutics, Inc. Quarterly
2022-05-09	10Q	BEAM/Beam Therapeutics, Inc. Quarterly

Receive BEAM News And Ratings

See the #1 stock for the next 7 days that we like better than BEAM

BEAM Financial Statistics

Sales & Book Value

Annual Sales:	$139.7M
Cash Flow:	$-87M
Price / Cash Flow:	0
Annual Sales:	$12.17
Price / Book:	2.23

Profitability

EPS (TTM):	-1.01570
Net Income (TTM):	$-80M
Gross Margin:	$117.4M
Return on Equity:	-7.83%
Return on Assets:	-5.92%

Beam Therapeutics, Inc. Earnings Forecast

Key Beam Therapeutics, Inc. Financial Ratios

The Gross Profit Margin over the past 19 years for BEAM is 84.05%.
The Selling, General & Administrative Expenses for BEAM have been equal to 81.45% of Gross Profit Margin.
The Research & Development expenses have been 293.12% of Revenue.
The Net Earning history of BEAM is -57.24% of Total Revenues.
Per Share Earnings over the last 19 years have been positive in 7 years.

Beam Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	BEAM
CUSIP:	07373V
Website:	beamtx.com

Debt

Debt-to-Equity Ratio:	0.12
Current Ratio:	13.09
Quick Ratio:	12.85

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

BEAM Technical Analysis vs Fundamental Analysis